CLINICAL_TRIALS
trial_result
· 2025-06-02
Clinical Trial Update: CS-206 in Patients With Sickle Cell Disease [EARLY_Phase 1]
Summary
CS-206 is planned for an early Phase 1 trial in patients with Sickle Cell Disease and is currently not yet recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Children's Hospital of Fudan University | Conditions: Sickle Cell Disease | EARLY_Phase 1 | Status: NOT_YET_RECRUITING